HK1018778A1 - Taxane derivatives having a pyridyl substituted c13 side chain, their preparation and their use as anti-tumor agents - Google Patents

Taxane derivatives having a pyridyl substituted c13 side chain, their preparation and their use as anti-tumor agents

Info

Publication number
HK1018778A1
HK1018778A1 HK99103795A HK99103795A HK1018778A1 HK 1018778 A1 HK1018778 A1 HK 1018778A1 HK 99103795 A HK99103795 A HK 99103795A HK 99103795 A HK99103795 A HK 99103795A HK 1018778 A1 HK1018778 A1 HK 1018778A1
Authority
HK
Hong Kong
Prior art keywords
microtubules
pct
taxol
depolymerisation
mitosis
Prior art date
Application number
HK99103795A
Other languages
English (en)
Inventor
Ulrich U Klar
Guenter G Neef
Hermann H Graf
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of HK1018778A1 publication Critical patent/HK1018778A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK99103795A 1996-01-31 1999-09-02 Taxane derivatives having a pyridyl substituted c13 side chain, their preparation and their use as anti-tumor agents HK1018778A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19605024A DE19605024A1 (de) 1996-01-31 1996-01-31 Neue selektive Taxane, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
PCT/EP1997/000440 WO1997028156A1 (en) 1996-01-31 1997-01-31 Taxane derivatives having a pyridyl substituted c13 side chain, their preparation and their use as anti-tumor agents

Publications (1)

Publication Number Publication Date
HK1018778A1 true HK1018778A1 (en) 2000-01-07

Family

ID=7785142

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99103795A HK1018778A1 (en) 1996-01-31 1999-09-02 Taxane derivatives having a pyridyl substituted c13 side chain, their preparation and their use as anti-tumor agents

Country Status (26)

Country Link
US (1) US6162920A (pl)
EP (1) EP0896577B1 (pl)
JP (1) JP2001505527A (pl)
KR (1) KR19990082151A (pl)
CN (1) CN1073108C (pl)
AT (1) ATE233757T1 (pl)
AU (1) AU714313B2 (pl)
BR (1) BR9708295A (pl)
CA (1) CA2244746A1 (pl)
CZ (1) CZ292504B6 (pl)
DE (2) DE19605024A1 (pl)
DK (1) DK0896577T3 (pl)
ES (1) ES2192261T3 (pl)
HK (1) HK1018778A1 (pl)
HU (1) HUP9901027A3 (pl)
IL (1) IL124951A (pl)
NO (1) NO983509L (pl)
PL (1) PL186796B1 (pl)
PT (1) PT896577E (pl)
RU (1) RU2163599C2 (pl)
SK (1) SK101198A3 (pl)
TR (1) TR199801415T2 (pl)
TW (1) TW444015B (pl)
UA (1) UA49007C2 (pl)
WO (1) WO1997028156A1 (pl)
ZA (1) ZA97847B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002070512A1 (fr) 2001-03-07 2002-09-12 Daiichi Pharmaceutical Co, Ltd. Procede de fabrication d'un derive d'azetidinone-2
WO2004078065A2 (en) 2003-03-03 2004-09-16 Sinus Rhythm Technologies, Inc. Electrical conduction block implant device
CN1296391C (zh) * 2004-03-04 2007-01-24 中国人民解放军第二军医大学 氟代羧烷基环糊精醚类化合物及其制备方法和应用
DK1746976T3 (en) 2004-05-03 2017-04-10 Merrimack Pharmaceuticals Inc LIPOSOMES SUITABLE FOR PHARMACEUTICAL SUPPLY
US8658203B2 (en) 2004-05-03 2014-02-25 Merrimack Pharmaceuticals, Inc. Liposomes useful for drug delivery to the brain
US9717724B2 (en) 2012-06-13 2017-08-01 Ipsen Biopharm Ltd. Methods for treating pancreatic cancer using combination therapies
AU2013202947B2 (en) 2012-06-13 2016-06-02 Ipsen Biopharm Ltd. Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
US11318131B2 (en) 2015-05-18 2022-05-03 Ipsen Biopharm Ltd. Nanoliposomal irinotecan for use in treating small cell lung cancer
PT3337467T (pt) 2015-08-20 2021-01-25 Ipsen Biopharm Ltd Terapia de combinação utilizando irinotecano lipossomal e um inibidor parp para tratamento do cancro
WO2017034957A1 (en) 2015-08-21 2017-03-02 Merrimack Pharmaceuticals, Inc. Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin
AU2016340153B2 (en) 2015-10-16 2022-06-02 Ipsen Biopharm Ltd. Stabilizing camptothecin pharmaceutical compositions
WO2018083470A1 (en) 2016-11-02 2018-05-11 Ipsen Biopharm Ltd. Treating gastric cancer using combination therapies comprising liposomal irinotecan, oxaliplatin, 5-fluoruracil (and leucovorin)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5489601A (en) * 1991-09-23 1996-02-06 Florida State University Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
PT690712E (pt) * 1993-03-22 2002-05-31 Univ Florida State Taxanos possuindo uma cadeia lateral substituida com piridilo
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
FR2715307B1 (fr) * 1994-01-25 1996-04-05 Commissariat Energie Atomique Procédé de solubilisation dans un milieu aqueux d'agents antitumoraux de la famille du taxol, et cyclodextrines ramifiées utilisables pour cette solubilisation.
DE69504843T2 (de) * 1994-06-28 1999-02-11 Upjohn Co 7-äther-taxol ähnliche verbindungen antineoplastische verwendung und diese enthaltende pharmazeutische zusammenstellungen

Also Published As

Publication number Publication date
DE69719502T2 (de) 2004-02-19
NO983509D0 (no) 1998-07-30
WO1997028156A1 (en) 1997-08-07
US6162920A (en) 2000-12-19
BR9708295A (pt) 1999-08-03
NO983509L (no) 1998-07-30
JP2001505527A (ja) 2001-04-24
RU2163599C2 (ru) 2001-02-27
CN1073108C (zh) 2001-10-17
CZ242698A3 (cs) 1999-07-14
DE69719502D1 (de) 2003-04-10
DK0896577T3 (da) 2003-05-19
ES2192261T3 (es) 2003-10-01
IL124951A0 (en) 1999-01-26
DE19605024A1 (de) 1997-08-07
AU1598497A (en) 1997-08-22
PT896577E (pt) 2003-06-30
AU714313B2 (en) 1999-12-23
CN1210535A (zh) 1999-03-10
PL328055A1 (en) 1999-01-04
CZ292504B6 (cs) 2003-10-15
EP0896577A1 (en) 1999-02-17
TR199801415T2 (xx) 1998-10-21
PL186796B1 (pl) 2004-02-27
IL124951A (en) 2003-12-10
HUP9901027A3 (en) 2001-08-28
UA49007C2 (uk) 2002-09-16
ZA97847B (en) 1997-08-04
TW444015B (en) 2001-07-01
EP0896577B1 (en) 2003-03-05
ATE233757T1 (de) 2003-03-15
HUP9901027A2 (hu) 2001-05-28
CA2244746A1 (en) 1997-08-07
KR19990082151A (ko) 1999-11-15
SK101198A3 (en) 1998-12-02

Similar Documents

Publication Publication Date Title
HK1018778A1 (en) Taxane derivatives having a pyridyl substituted c13 side chain, their preparation and their use as anti-tumor agents
RU2213097C2 (ru) Гетероциклы в качестве ингибиторов адгезии лейкоцитов и vla-4-антагонистов
AU3968589A (en) Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
RU94042922A (ru) Новые соединения, способы их получения, фармацевтическая композиция
EA200100553A1 (ru) Замещенные бициклические производные, полезные в качестве противораковых агентов
ES8105283A1 (es) Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas
CA2124329A1 (en) Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
RU94039542A (ru) Производные пиперазина как антагонисты 5-нт-рецепторов, способ получения, фармацевтическая композиция
RU95105246A (ru) Производные азотистого иприта, связанные с аминокислотами, используемые в качестве пролекарств, фармацевтическая композиция, двухкомпонентная система и способ лечения опухолей
FI935821A0 (fi) Fosfonooximetylestrar av taxanderivat
FI956341A0 (fi) Metyylifosfonihappoesteri, menetelmä sen valmistamiseksi ja sen käyttö
RU94040859A (ru) Аминопроизводные оксо- и гидрокси-замещенных углеводородов, способы получения, фармацевтические композиции, способ ингибирования ретровирусной протеазы, способ лечения спида у млекопитающих
EA012625B1 (ru) Цитотоксические агенты, содержащие новые таксаны
ES2168304T3 (es) Derivados del taxol.
AU6369900A (en) Aromatic esters of camptothecins and methods to treat cancers
JO1696B1 (en) Acetamide derivatives
RU94036745A (ru) Производные галантамина и фармацевтическая композиция
DE59300176D1 (de) 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
FI935800A0 (fi) Antidepressiva och mot Parkisons sjukdom verksamma foereningar
EP0531419A4 (en) Bistriazenes as chemotherapeutic agents
TW364905B (en) Lactone compound and process of production thereof
DZ3046A1 (fr) Hydroxamides d'acides 3-(arylsulfonylamino)-tétrahydropyranne-3-carboxyliques, procédé pour leur préparation et compositions pharmaceutiques les contenant.
von Angerer New inhibitors of tubulin polymerisation
RU94014631A (ru) Производные 4-хиномиодигидропиридина, смесь их изомеров или отдельные изомеры и их соли
RU94000064A (ru) Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060131